Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Veterinary dermatology drugs market 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Region trends
2.1.3 Indication trends
2.1.4 Route of administration trends
2.1.5 Distribution channel trends
Chapter 3 Veterinary Dermatology Drugs Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing pet ownership
3.2.1.2 Rising incidence of dermatological diseases
3.2.1.3 Technological advancements in veterinary dermatology
3.2.1.4 Increasing animal medicalization rates
3.2.1.5 Increasing number of veterinary dermatology practitioners
3.2.1.6 Increased spending on animal healthcare
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse side effects and safety concerns
3.2.2.2 High cost of drug development
3.3 Growth potential analysis
3.3.1 By drug class
3.3.2 By indication
3.3.3 By route of administration
3.3.4 By animal type
3.3.5 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix, 2022
4.6 Strategic dashboard, 2022
Chapter 5 Veterinary Dermatology Drugs Market Estimates and Forecast, By Drug Class (USD Million)
5.1 Key trends, by drug class
5.2 Antibacterial drugs
5.3 Antifungal drugs
5.4 Antiparasitic drugs
5.5 Other drug classes
Chapter 6 Veterinary Dermatology Drugs Market Estimates and Forecast, By Indication (USD Million)
6.1 Key trends, by indication
6.2 Parasitic infections
6.3 Allergic infections
6.4 Autoimmune skin diseases
6.5 Skin cancer
6.6 Other indications
Chapter 7 Veterinary Dermatology Drugs Market Estimates and Forecast, By Route of Administration (USD Million)
7.1 Key trends, by route of administration
7.2 Injectable
7.3 Topical
7.4 Oral
Chapter 8 Veterinary Dermatology Drugs Market Estimates and Forecast, By Animal Type (USD Million)
8.1 Key trends, by animal type
8.2 Companion animal
8.2.1 Dogs
8.2.2 Cats
8.2.3 Horses
8.2.4 Other companion animals
8.3 Livestock animal
8.3.1 Bovine
8.3.2 Swine
8.3.3 Other livestock animals
Chapter 9 Veterinary Dermatology Drugs Market Estimates and Forecast, By Distribution Channel (USD Million)
9.1 Key trends, by distribution channel
9.2 Hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies
Chapter 10 Veterinary Dermatology Drugs Market Estimates and Forecast, By Region (USD Million)
10.1 North America
10.1.1 U.S.
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 UK
10.2.3 France
10.2.4 Spain
10.2.5 Italy
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 Rest of Asia Pacific
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Rest of Latin America
10.5 Middle East & Africa
10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Elanco Animal Health Incorporated
11.2 Vetoquinol S.A.
11.3 Ceva
11.4 Merck & Co., Inc.
11.5 Zoetis, Inc.
11.6 Virbac
11.7 Bimeda, Inc.
11.8 Vivaldis
11.9 Bioiberica S.A.U
11.10 Indian Immunologicals Ltd.
